Copyright Reports & Markets. All rights reserved.

Global In Silico Clinical Trials Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global In Silico Clinical Trials Market Size 2017-2028
    • 2.1.2 In Silico Clinical Trials Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 In Silico Clinical Trials Segment by Phase
    • 2.2.1 Phase I
    • 2.2.2 Phase II
    • 2.2.3 Phase III
    • 2.2.4 Phase IV
  • 2.3 In Silico Clinical Trials Market Size by Phase
    • 2.3.1 In Silico Clinical Trials Market Size CAGR by Phase (2017 VS 2022 VS 2028)
    • 2.3.2 Global In Silico Clinical Trials Market Size Market Share by Phase (2017-2022)
  • 2.4 In Silico Clinical Trials Segment by Application
    • 2.4.1 Oncology
    • 2.4.2 Infectious Disease
    • 2.4.3 Hematology
    • 2.4.4 Cardiology
    • 2.4.5 Dermatology
    • 2.4.6 Neurology
    • 2.4.7 Diabetes
    • 2.4.8 Others
  • 2.5 In Silico Clinical Trials Market Size by Application
    • 2.5.1 In Silico Clinical Trials Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global In Silico Clinical Trials Market Size Market Share by Application (2017-2022)

3 In Silico Clinical Trials Market Size by Player

  • 3.1 In Silico Clinical Trials Market Size Market Share by Players
    • 3.1.1 Global In Silico Clinical Trials Revenue by Players (2020-2022)
    • 3.1.2 Global In Silico Clinical Trials Revenue Market Share by Players (2020-2022)
  • 3.2 Global In Silico Clinical Trials Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 In Silico Clinical Trials by Regions

  • 4.1 In Silico Clinical Trials Market Size by Regions (2017-2022)
  • 4.2 Americas In Silico Clinical Trials Market Size Growth (2017-2022)
  • 4.3 APAC In Silico Clinical Trials Market Size Growth (2017-2022)
  • 4.4 Europe In Silico Clinical Trials Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa In Silico Clinical Trials Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas In Silico Clinical Trials Market Size by Country (2017-2022)
  • 5.2 Americas In Silico Clinical Trials Market Size by Phase (2017-2022)
  • 5.3 Americas In Silico Clinical Trials Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC In Silico Clinical Trials Market Size by Region (2017-2022)
  • 6.2 APAC In Silico Clinical Trials Market Size by Phase (2017-2022)
  • 6.3 APAC In Silico Clinical Trials Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe In Silico Clinical Trials by Country (2017-2022)
  • 7.2 Europe In Silico Clinical Trials Market Size by Phase (2017-2022)
  • 7.3 Europe In Silico Clinical Trials Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa In Silico Clinical Trials by Region (2017-2022)
  • 8.2 Middle East & Africa In Silico Clinical Trials Market Size by Phase (2017-2022)
  • 8.3 Middle East & Africa In Silico Clinical Trials Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global In Silico Clinical Trials Market Forecast

  • 10.1 Global In Silico Clinical Trials Forecast by Regions (2023-2028)
    • 10.1.1 Global In Silico Clinical Trials Forecast by Regions (2023-2028)
    • 10.1.2 Americas In Silico Clinical Trials Forecast
    • 10.1.3 APAC In Silico Clinical Trials Forecast
    • 10.1.4 Europe In Silico Clinical Trials Forecast
    • 10.1.5 Middle East & Africa In Silico Clinical Trials Forecast
  • 10.2 Americas In Silico Clinical Trials Forecast by Country (2023-2028)
    • 10.2.1 United States In Silico Clinical Trials Market Forecast
    • 10.2.2 Canada In Silico Clinical Trials Market Forecast
    • 10.2.3 Mexico In Silico Clinical Trials Market Forecast
    • 10.2.4 Brazil In Silico Clinical Trials Market Forecast
  • 10.3 APAC In Silico Clinical Trials Forecast by Region (2023-2028)
    • 10.3.1 China In Silico Clinical Trials Market Forecast
    • 10.3.2 Japan In Silico Clinical Trials Market Forecast
    • 10.3.3 Korea In Silico Clinical Trials Market Forecast
    • 10.3.4 Southeast Asia In Silico Clinical Trials Market Forecast
    • 10.3.5 India In Silico Clinical Trials Market Forecast
    • 10.3.6 Australia In Silico Clinical Trials Market Forecast
  • 10.4 Europe In Silico Clinical Trials Forecast by Country (2023-2028)
    • 10.4.1 Germany In Silico Clinical Trials Market Forecast
    • 10.4.2 France In Silico Clinical Trials Market Forecast
    • 10.4.3 UK In Silico Clinical Trials Market Forecast
    • 10.4.4 Italy In Silico Clinical Trials Market Forecast
    • 10.4.5 Russia In Silico Clinical Trials Market Forecast
  • 10.5 Middle East & Africa In Silico Clinical Trials Forecast by Region (2023-2028)
    • 10.5.1 Egypt In Silico Clinical Trials Market Forecast
    • 10.5.2 South Africa In Silico Clinical Trials Market Forecast
    • 10.5.3 Israel In Silico Clinical Trials Market Forecast
    • 10.5.4 Turkey In Silico Clinical Trials Market Forecast
    • 10.5.5 GCC Countries In Silico Clinical Trials Market Forecast
  • 10.6 Global In Silico Clinical Trials Forecast by Phase (2023-2028)
  • 10.7 Global In Silico Clinical Trials Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Certara, Inc.
    • 11.1.1 Certara, Inc. Company Information
    • 11.1.2 Certara, Inc. In Silico Clinical Trials Product Offered
    • 11.1.3 Certara, Inc. In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Certara, Inc. Main Business Overview
    • 11.1.5 Certara, Inc. Latest Developments
  • 11.2 Novadiscovery Sas
    • 11.2.1 Novadiscovery Sas Company Information
    • 11.2.2 Novadiscovery Sas In Silico Clinical Trials Product Offered
    • 11.2.3 Novadiscovery Sas In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Novadiscovery Sas Main Business Overview
    • 11.2.5 Novadiscovery Sas Latest Developments
  • 11.3 Insilico Medicine, Inc.
    • 11.3.1 Insilico Medicine, Inc. Company Information
    • 11.3.2 Insilico Medicine, Inc. In Silico Clinical Trials Product Offered
    • 11.3.3 Insilico Medicine, Inc. In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Insilico Medicine, Inc. Main Business Overview
    • 11.3.5 Insilico Medicine, Inc. Latest Developments
  • 11.4 Dassault Systemes SE
    • 11.4.1 Dassault Systemes SE Company Information
    • 11.4.2 Dassault Systemes SE In Silico Clinical Trials Product Offered
    • 11.4.3 Dassault Systemes SE In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Dassault Systemes SE Main Business Overview
    • 11.4.5 Dassault Systemes SE Latest Developments
  • 11.5 GNS Healthcare Inc.
    • 11.5.1 GNS Healthcare Inc. Company Information
    • 11.5.2 GNS Healthcare Inc. In Silico Clinical Trials Product Offered
    • 11.5.3 GNS Healthcare Inc. In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 GNS Healthcare Inc. Main Business Overview
    • 11.5.5 GNS Healthcare Inc. Latest Developments
  • 11.6 The AnyLogic Company
    • 11.6.1 The AnyLogic Company Company Information
    • 11.6.2 The AnyLogic Company In Silico Clinical Trials Product Offered
    • 11.6.3 The AnyLogic Company In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 The AnyLogic Company Main Business Overview
    • 11.6.5 The AnyLogic Company Latest Developments
  • 11.7 InSilicoTrials
    • 11.7.1 InSilicoTrials Company Information
    • 11.7.2 InSilicoTrials In Silico Clinical Trials Product Offered
    • 11.7.3 InSilicoTrials In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 InSilicoTrials Main Business Overview
    • 11.7.5 InSilicoTrials Latest Developments
  • 11.8 Immunetrics Inc.
    • 11.8.1 Immunetrics Inc. Company Information
    • 11.8.2 Immunetrics Inc. In Silico Clinical Trials Product Offered
    • 11.8.3 Immunetrics Inc. In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Immunetrics Inc. Main Business Overview
    • 11.8.5 Immunetrics Inc. Latest Developments
  • 11.9 Nuventra Pharma Sciences
    • 11.9.1 Nuventra Pharma Sciences Company Information
    • 11.9.2 Nuventra Pharma Sciences In Silico Clinical Trials Product Offered
    • 11.9.3 Nuventra Pharma Sciences In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Nuventra Pharma Sciences Main Business Overview
    • 11.9.5 Nuventra Pharma Sciences Latest Developments
  • 11.10 Abzena Ltd.
    • 11.10.1 Abzena Ltd. Company Information
    • 11.10.2 Abzena Ltd. In Silico Clinical Trials Product Offered
    • 11.10.3 Abzena Ltd. In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Abzena Ltd. Main Business Overview
    • 11.10.5 Abzena Ltd. Latest Developments
  • 11.11 Siemens
    • 11.11.1 Siemens Company Information
    • 11.11.2 Siemens In Silico Clinical Trials Product Offered
    • 11.11.3 Siemens In Silico Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Siemens Main Business Overview
    • 11.11.5 Siemens Latest Developments

12 Research Findings and Conclusion

As the global economy mends, the 2021 growth of In Silico Clinical Trials will have significant change from previous year. According to our (LP Information) latest study, the global In Silico Clinical Trials market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global In Silico Clinical Trials market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States In Silico Clinical Trials market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global In Silico Clinical Trials market, reaching US$ million by the year 2028. As for the Europe In Silico Clinical Trials landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main In Silico Clinical Trials players cover Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., and Dassault Systemes SE, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of In Silico Clinical Trials market by product type, application, key players and key regions and countries.

Segmentation by phase: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Phase I
Phase II
Phase III
Phase IV

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Oncology
Infectious Disease
Hematology
Cardiology
Dermatology
Neurology
Diabetes
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Certara, Inc.
Novadiscovery Sas
Insilico Medicine, Inc.
Dassault Systemes SE
GNS Healthcare Inc.
The AnyLogic Company
InSilicoTrials
Immunetrics Inc.
Nuventra Pharma Sciences
Abzena Ltd.
Siemens
Buy now